Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-05

Clinical Trial Update: Impact of Aversive Warnings on E-Cigarette Cessation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from University of California, San Diego is evaluating the impact of aversive warnings on e-cigarette cessation; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: E Cigarette Use | Phase 3 | Status: NOT_YET_RECRUITING